Dr. Reddy’s Laboratories’ (DRL ... US sales posted growth of 15.6% YoY to USD 445mn, likely driven by gRevlimid (pegged at ...

HYDERABAD: Pharma major Dr Reddy's Laboratories on Tuesday reported a 15% drop in ... Consolidated net profit for Q2 fell to ...

Dr Reddys Laboratories Q2 Results Live : Dr Reddys Laboratories announced its Q2 results on November 5, 2024, revealing a ...

ALSO READ: Dr Reddy's clocks highest-ever revenue in Q2; net profit down 9.5% Meanwhile, Delhi-based Mankind Pharma reported ...

Dr Reddy’s Lab led the gainers on NSE ... However, he cautioned that “poor earnings growth in Q2 and earnings downgrades for ...

The gross non-performing asset (GNPA) ratio was 2.43% in the September quarter, compared to 1.96% in the June quarter.

Muthoot Microfin’s net profit for the second quarter fell 44% year on year to ₹61.6 Crore, owing mostly to stress in the ...

Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While ...

Get Rs 5 Lakh Health Cover: How Senior Citizens Can Enroll For Ayushman Bharat Vaya Vandana Card IRCTC Q2 Results: Railway ...

Dr. Reddy's' US sales continued to struggle due to inventory adjustments and pricing pressures on key products, Citi said.

The brokerage expects the new business avenues to take a few years before they start contributing profitably to the ...